COMMONWEALTH EQUITY SERVICES, LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 312272 WALTHAM, MA

Position in CAPR

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$644,742

-$168,518 QoQ

Shares Held

26,775

+0.1% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 169 holders

Holding Since

Mar 2023

14 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. CAPR ranks #37 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$644,742	26,775	+0.1%	Shares	Sole	2026-07-29
2026-03-31	$813,260	26,752	+1.8%	Shares	Sole	2026-04-27
2025-12-31	$758,671	26,288	-14.8%	Shares	Sole	2026-02-12
2025-09-30	$222,500	30,860	-0.0%	Shares	Sole	2025-10-22
2025-06-30	$306,459	30,862	-0.0%	Shares	Sole	2025-08-06
2025-03-31	$292,937	30,868	+0.7%	Shares	Sole	2025-05-09
2024-12-31	$423,080	30,658	-2.0%	Shares	Sole	2025-02-10
2024-09-30	$475,768	31,280	+4.3%	Shares	Sole	2024-10-18
2024-06-30	$143,100	30,000	-3.2%	Shares	Sole	2024-07-31
2024-03-31	$210,422	30,990	0.0%	Shares	Sole	2024-04-29
2023-12-31	$151,541	30,990	0.0%	Shares	Sole	2024-02-06
2023-09-30	$105,985	30,990	+3.3%	Shares	Sole	2023-10-23
2023-06-30	$143,400	30,000	0.0%	Shares	Sole	2023-08-10
2023-03-31	$126,600	30,000	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.